Xue Chao

1.1k total citations
29 papers, 416 citations indexed

About

Xue Chao is a scholar working on Pathology and Forensic Medicine, Oncology and Cancer Research. According to data from OpenAlex, Xue Chao has authored 29 papers receiving a total of 416 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pathology and Forensic Medicine, 10 papers in Oncology and 8 papers in Cancer Research. Recurrent topics in Xue Chao's work include Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xue Chao is often cited by papers focused on Breast Cancer Treatment Studies (7 papers), Breast Lesions and Carcinomas (7 papers) and Cancer Immunotherapy and Biomarkers (4 papers). Xue Chao collaborates with scholars based in China, Netherlands and Canada. Xue Chao's co-authors include Rongzhen Luo, Peng Sun, Yan Nie, Jing‐Ping Yun, Yandan Yao, Jiayi Zeng, Lili Liu, Yang Xia, Jiehua He and Kai Chen and has published in prestigious journals such as Blood, Journal of the American College of Cardiology and Cancer Research.

In The Last Decade

Xue Chao

24 papers receiving 399 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xue Chao China 13 176 129 107 76 64 29 416
Rathi Ramakrishnan United Kingdom 12 211 1.2× 180 1.4× 120 1.1× 173 2.3× 210 3.3× 29 797
Hirofumi Yamada Japan 15 231 1.3× 55 0.4× 51 0.5× 168 2.2× 85 1.3× 78 731
Itai Pashtan United States 11 164 0.9× 121 0.9× 54 0.5× 153 2.0× 166 2.6× 25 504
Daniel Schmolze United States 15 254 1.4× 136 1.1× 49 0.5× 89 1.2× 278 4.3× 41 791
Giada Munari Italy 15 199 1.1× 154 1.2× 98 0.9× 95 1.3× 170 2.7× 50 517
Leen Slaets Belgium 16 436 2.5× 544 4.2× 282 2.6× 115 1.5× 76 1.2× 45 960
Chithra Sangli United States 8 215 1.2× 230 1.8× 103 1.0× 87 1.1× 194 3.0× 21 720
Shristi Bhattarai United States 14 239 1.4× 162 1.3× 45 0.4× 72 0.9× 114 1.8× 28 442
Wei Qiang Leow Singapore 13 200 1.1× 166 1.3× 75 0.7× 86 1.1× 133 2.1× 47 717

Countries citing papers authored by Xue Chao

Since Specialization
Citations

This map shows the geographic impact of Xue Chao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xue Chao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xue Chao more than expected).

Fields of papers citing papers by Xue Chao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xue Chao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xue Chao. The network helps show where Xue Chao may publish in the future.

Co-authorship network of co-authors of Xue Chao

This figure shows the co-authorship network connecting the top 25 collaborators of Xue Chao. A scholar is included among the top collaborators of Xue Chao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xue Chao. Xue Chao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Qianhui, Qi Guo, Xue Chao, et al.. (2025). Development and validation of a multi-modal MRI-based deep learning framework for differentiation of intraspinal tumors (ISMF-Net). EClinicalMedicine. 90. 103636–103636.
5.
Chao, Xue, Ying Zhang, Chengyou Zheng, et al.. (2023). Metastasis of breast cancer to bones alters the tumor immune microenvironment. European journal of medical research. 28(1). 119–119. 10 indexed citations
6.
Chao, Xue, Qing Li, Wen-Hai Tan, et al.. (2023). Determining the Eccentricity of Source Masses in the Measurement of Newtonian Gravitational Constant Using an Air-Bearing Method. Physical Review Applied. 19(6). 1 indexed citations
7.
Lu, Lianghe, Zhangping He, Run‐Cong Nie, et al.. (2022). C-Reactive Protein Levels Predict Responses to PD-1 Inhibitors in Hepatocellular Carcinoma Patients. Frontiers in Immunology. 13. 808101–808101. 29 indexed citations
8.
Du, Tian, Lu Pan, Chengyou Zheng, et al.. (2022). Matrix Gla protein (MGP), GATA3, and TRPS1: a novel diagnostic panel to determine breast origin. Breast Cancer Research. 24(1). 70–70. 13 indexed citations
9.
Sun, Peng, Jiehua He, Xue Chao, et al.. (2021). A Computational Tumor-Infiltrating Lymphocyte Assessment Method Comparable with Visual Reporting Guidelines for Triple-Negative Breast Cancer. EBioMedicine. 70. 103492–103492. 40 indexed citations
10.
Chao, Xue, Xiaoyan Jin, Cui Tan, et al.. (2020). Re-excision or “wait and watch”—a prediction model in breast phyllodes tumors after surgery. Annals of Translational Medicine. 8(6). 371–371. 16 indexed citations
11.
Sun, Peng, Qianyi Lu, Xue Chao, et al.. (2020). Mucinous carcinoma with micropapillary features is morphologically, clinically and genetically distinct from pure mucinous carcinoma of breast. Modern Pathology. 33(10). 1945–1960. 16 indexed citations
12.
Chao, Xue, Zixian Wang, Shi‐Xun Lu, et al.. (2020). Signet ring cell component in pretreatment biopsy predicts pathological response to preoperative chemoradiotherapy in rectal cancer. International Journal of Clinical Oncology. 25(9). 1653–1662. 2 indexed citations
13.
Chao, Xue, Lili Liu, Peng Sun, et al.. (2020). Immune parameters associated with survival in metaplastic breast cancer. Breast Cancer Research. 22(1). 92–92. 24 indexed citations
14.
Liu, Lili, Shiwen Zhang, Xue Chao, et al.. (2020). Coexpression of CMTM6 and PD-L1 as a predictor of poor prognosis in macrotrabecular-massive hepatocellular carcinoma. Cancer Immunology Immunotherapy. 70(2). 417–429. 52 indexed citations
15.
He, Jiehua, Julia Y. Tsang, Xiaodan Xu, et al.. (2020). AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer. BMC Cancer. 20(1). 18–18. 18 indexed citations
16.
Sui, Qiaoqi, Jian Zheng, Dingxin Liu, et al.. (2019). Dickkopf-related protein 1, a new biomarker for local immune status and poor prognosis among patients with colorectal liver Oligometastases: a retrospective study. BMC Cancer. 19(1). 1210–1210. 16 indexed citations
17.
Chao, Xue, et al.. (2019). HALF NORMAL SALINE SHORTENS THE TIME TO ACHIEVE BIDIRECTIONAL BLOCK IN TYPICAL ATRIAL FLUTTER. Journal of the American College of Cardiology. 73(9). 508–508. 1 indexed citations
18.
Chao, Xue, Kai Chen, Jiayi Zeng, et al.. (2019). Adjuvant radiotherapy and chemotherapy for patients with breast phyllodes tumors: a systematic review and meta-analysis. BMC Cancer. 19(1). 372–372. 52 indexed citations
19.
Nie, Yan, Jianing Chen, Di Huang, et al.. (2017). Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation. Cancer Research. 77(13). 3605–3618. 43 indexed citations
20.
Chao, Xue, et al.. (2014). GW25-e4543 The relationship of thyroid function and the severity of coronary artery in patients with coronary artery disease. Journal of the American College of Cardiology. 64(16). C121–C121. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026